시장보고서
상품코드
2106670

디지털 창상 측정 기기 : 시장 인사이트, 경쟁 구도 및 시장 예측(-2034년)

Digital Wound Measurement Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

발행일: | 리서치사: 구분자 DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 3,750 금액 안내 화살표 ₩ 5,147,000
PDF & Excel (2-3 User License) help
PDF 및 Excel 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. PDF·Excel 내 텍스트 등의 복사 및 붙여넣기는 가능하나, 사내 이용으로만 제한됩니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,688 금액 안내 화살표 ₩ 6,434,000
PDF & Excel (Site License) help
PDF 및 Excel 보고서를 동일 사업장(소재지) 내 모든 분이 이용할 수 있는 라이선스입니다. PDF·Excel 내 텍스트 등의 복사 및 붙여넣기는 가능하나, 사내 이용으로만 제한됩니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,625 금액 안내 화살표 ₩ 7,720,000
PDF & Excel (Global License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. PDF·Excel 내 텍스트 등의 복사 및 붙여넣기는 가능하나, 사내 이용으로만 제한됩니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,500 금액 안내 화살표 ₩ 10,294,000
※ 부가세 별도
한글목차
영문목차

개요:

  • 디지털 상처 측정 기기 시장은 2025년에 2억 6,050만 달러로 추정되며, 2034년까지 5억 5,270만 달러에 달할 것으로 예측됩니다. 이러한 성장의 배경에는 전 세계적으로 증가하는 만성 및 복합 상처의 부담, 수작업 평가에서 영상 진단 중심의 디지털 평가로의 전환, 그리고 병원 및 전문 상처 치료 시설에서의 AI 기반 상처 분석 도입 확대가 있습니다.
  • 전 세계 디지털 상처 측정 기기 시장은 2026년부터 2034년까지의 예측 기간 동안 연평균 성장률(CAGR) 8.5%로 성장하고 있습니다.
  • 제품 유형별로는 2025년에 소프트웨어 부문이 58%의 점유율을 차지하며 디지털 상처 측정 기기 시장을 주도했습니다.
  • 측정 기술별로는 2D 영상 진단 부문이 2025년에 50%의 점유율을 차지하며 디지털 상처 측정 기기 시장을 주도했습니다.
  • 상처 유형별로는 2025년에 당뇨병성 족부 궤양 부문이 38%의 점유율을 차지하며 디지털 상처 측정 기기 시장을 주도했습니다.
  • 측정 방식별로는 2025년에 비접촉 부문이 디지털 상처 측정 기기 시장에서 60%의 점유율을 차지하며 시장을 주도했습니다.
  • 최종 사용자별로는 2025년에 병원 및 진료소 부문이 56%의 점유율을 차지하며 디지털 상처 측정 기기 시장을 주도했습니다.
  • 2025년, 북미는 전 세계 디지털 상처 측정 기기 시장 매출에서 42%의 점유율을 차지하며, 전 세계적으로 가장 높은 지역별 시장 점유율을 기록했습니다.

디지털 상처 측정 기기는 자, 아세테이트 트레이싱, 또는 육안 측정과 같은 수동적인 방법보다 높은 정확도와 일관성을 바탕으로 길이, 너비, 깊이, 면적, 부피 등 상처의 치수를 측정, 정량화, 기록하는 하드웨어 또는 소프트웨어를 활용한 시스템입니다. 당뇨병성 족부 궤양, 욕창, 정맥성 하지 궤양 등의 만성 상처는 수주에서 수개월에 걸쳐 반복적으로 평가해야 하므로, 임상의들은 이미징 센서, 구조화된 빛, 레이저 스캔 또는 컴퓨터 비전 알고리즘을 결합하여, 치유 경과에 관한 표준화되고 추적 가능한 시각적 이력을 구축하는 디지털 측정 플랫폼에 대한 의존도를 높이고 있습니다. 이러한 솔루션은 전용 하드웨어 장치나 독립형 소프트웨어 용도에 이르기까지 다양하며, 2D 이미징, 3D 이미징, AI 및 컴퓨터 비전, 레이저 기반 이미징 등의 기술을 채택하고 있으며, 접촉식 및 비접촉식 양쪽 방식으로 도입되어 당뇨병성 족부 궤양, 욕창 및 외상, 화상, 기타 상처 유형을 평가하는 데 활용되고 있습니다. 이 시장은 제품 유형별(디바이스 및 소프트웨어), 측정 기술별(2D 이미징, 3D 이미징, AI 및 컴퓨터 비전, 레이저 기반 이미징 등), 상처 유형별(당뇨병성 족부 궤양, 욕창/외상, 화상이 주를 이룸), 측정 방식별(접촉식 및 비접촉식 시스템), 최종 사용자별(병원 및 진료소가 중심)로 분류됩니다. 전 세계 만성 상처 유병률 증가, 표준화되고 감염 관리에 적합한 비접촉식 평가로의 전환, 그리고 AI를 활용한 분석 기능 및 전자건강기록(EHR)과의 연동 발전 등에 힘입어, 디지털 상처 측정 기기는 현대의 데이터 기반 상처 관리 프로그램에서 점점 더 필수적인 요소가 되고 있습니다.

디지털 상처 측정 기기 시장의 주요 성장 동인

  • 당뇨병성 족부 궤양, 욕창, 정맥성 하퇴 궤양 등 만성적이고 복잡한 상처로 인한 전 세계적 부담이 증가함에 따라, 장기간에 걸친 치료 주기에서 반복적이고 표준화된 평가를 지원하는 도구에 대한 수요가 확대되고 있습니다.
  • 수동 접촉식 측정에서 비접촉식 영상 진단을 주축으로 한 평가로의 구조적 전환이 도입을 가속화하고 있습니다. 이는 비접촉식 시스템이 감염 예방에 기여하고, 환자의 불편감을 줄이며, 확인 가능한 시각적 기록을 생성하기 때문입니다.
  • 상처 영상 진단 플랫폼에 인공지능(AI) 및 컴퓨터 비전이 통합되면서 측정 속도, 일관성 및 임상 의사 결정 지원이 향상되고 있습니다. 그 대표적인 예가 2024년 10월 Swift Medical사가 출시한 AI 기반 ‘Skin &Wound 2’ 플랫폼입니다.
  • 디지털 상처 관리 플랫폼에 대한 투자자 및 전략적 관심이 높아지면서 시설 확충이 가속화되고 있습니다. 그 예로, 2025년 1월 MolecuLight가 Hayfin Capital Management로부터 2,750만 달러의 투자를 유치한 것을 들 수 있습니다.
  • 의료 시스템에서는 기록의 질 향상, 임상의 간 상처 평가의 표준화, 그리고 보험 청구 지원 강화가 요구되고 있으며, 자나 종이 메모, 주관적인 추정보다 디지털 도구가 우선시되고 있습니다.
  • 원격 의료, 원격 환자 모니터링, EHR/EMR 상호 운용성을 포함한 상처 관리의 디지털 전환이 확대됨에 따라, 대상 시장은 병원에서 전문 클리닉 및 재택 간호로 확대되고 있습니다.
  • 만성 질환 유병률 증가, 비접촉식 및 AI 기반 영상 진단 기술의 보급, 그리고 커넥티드 케어에 대한 투자가 맞물리면서 2034년까지 시장은 꾸준한 성장을 유지할 것으로 예측됩니다.

디지털 상처 측정 기기 시장 성장에 기여하는 요인

시장 성장 촉진요인

만성 및 복합성 상처로 인한 전 세계적 부담 증가

디지털 상처 측정 기기 시장의 가장 강력한 촉진요인은 일회성 평가가 아닌, 반복적인 경과 관찰이 필요한 상처를 안고 생활하는 환자가 꾸준히 증가하고 있다는 점입니다. 만성 상처는 당뇨병, 운동 기능 저하, 혈관 기능 부전, 고령화와 밀접한 관련이 있으며, 인구 고령화가 진행되고 장기적인 질환 관리 부담이 증가함에 따라 그 존재감이 점점 더 두드러지고 있습니다. 미국에서만 650만 명 이상이 만성 상처를 앓고 있으며, 연간 약 250억 달러의 의료비가 발생하고 있습니다. 또한 독일, 호주 및 기타 선진국 시장에서도 유사한 부담이 보고되고 있습니다. 이러한 경우, 상처 평가는 일회성 측정이 아니라 경과를 추적하고, 치유 지연을 파악하며, 적시에 치료 변경을 지원하는 지속적인 과정이 됩니다. 디지털 측정 기기는 상처의 경과를 시각적으로 기록하고, 특히 여러 의료진이 여러 차례의 진료에 걸쳐 동일한 환자를 진료하는 환경에서 의료 제공업체 간의 평가 편차를 줄임으로써 이러한 요구를 충족시키고 있습니다. 상처 관리 과정이 더욱 체계화됨에 따라, 의료 제공업체들은 일관성을 높이고 추측에 기반한 판단을 줄여주는 도구를 점점 더 중요하게 여기게 되었으며, 이것이 2034년까지 시장 성장 기반이 되고 있습니다.

비접촉식·이미지 주도형 평가로의 전환

수동 및 접촉형 측정에서 비접촉·영상 주도형 평가로의 구조적 전환이 시장을 재편하고 있습니다. 비접촉형 시스템을 통해 임상의는 상처 부위를 물리적으로 만지지 않고도 평가를 수행할 수 있으며, 동시에 측정 및 기록을 지원하는 영상을 촬영할 수 있습니다. 이는 감염 관리, 환자의 편안함, 재현 가능한 경과 관찰이 극히 중요시되는 현대의 상처 관리에서 매우 중요한 요소입니다. 의료 제공업체들은 특히 대규모 병원이나 여러 거점에 걸쳐 운영되는 상처 관리 프로그램에서 임상의 간의 표준화를 지원하는 시스템을 점점 더 중시하고 있으며, 이를 통해 측정과 사진 촬영, 소프트웨어 기반 분석, 구조화된 기록 기능을 결합한 이미지 기반 플랫폼이 자나 아세테이트 트레이싱을 대체하며 시장에서 입지를 다지고 있습니다.

시장 성장 억제요인

꾸준한 성장세를 보이고 있음에도 불구하고, 디지털 상처 측정 기기 시장은 중대한 제약에 직면해 있습니다. 예산 압박과 임상 현장의 도입 현황 불균형은 여전히 현실적인 제약 요인으로 작용하고 있습니다. 많은 의료 기관, 특히 소규모 시설, 외래 진료 센터 및 비용 제약이 심한 시장에 위치한 기관들은 가격에 민감하며, 수동 측정 도구가 익숙하고 저렴하다는 한, 디지털 측정 도구는 적절하긴 하지만 필수적인 것은 아니라고 간주할 가능성이 있습니다. 워크플로우의 혼란도 또 다른 장벽이 되고 있습니다. 설령 기기가 기록의 질을 향상시켜 준다 하더라도, 절차가 늘어나거나 교육이 필요하거나 기존 기록 시스템과 원활하게 연동되지 않는 경우, 임상의들은 도입을 주저할 수 있습니다. 시장에는 영상 진단, 측정, 기록 관리 솔루션이 파편적으로 혼재되어 있어 구매 결정을 복잡하게 만들고 있으며, 공급업체는 임상적 관점뿐만 아니라 시간 절약 및 업무 효율성 측면에서도 가치를 입증해야 합니다. 병원과 외래수술센터(ASC)부터 전문 클리닉, 재택 간호에 이르기까지 매우 다양한 의료 현장에서 일관된 임상적 가치를 입증하는 것은 여전히 핵심 과제입니다. 전문 상처 치료 센터에서는 우수한 성능을 발휘하는 기기라 할지라도, 일반 병원의 병동이나 자원이 제한된 외래 환경에서는 쉽게 채택되지 않을 가능성이 있기 때문입니다. 지역별 보험 환급 제도의 차이, 신흥 시장의 디지털 인프라 부족, 그리고 기술적 역량을 측정 가능한 성과로 전환해야 할 필요성이 도입 속도를 더욱 둔화시키고 있습니다. 한편, 만성 상처 유병률 증가나 디지털 전환과 같은 근본적인 촉진요인은 여전히 확고하게 존재하고 있습니다.

자주 묻는 질문

  • 디지털 상처 측정 기기 시장 규모는 어떻게 예측되나요?
  • 디지털 상처 측정 기기 시장에서 소프트웨어 부문의 점유율은 어떻게 되나요?
  • 디지털 상처 측정 기기 시장에서 2D 영상 진단 부문의 점유율은 어떻게 되나요?
  • 디지털 상처 측정 기기 시장에서 당뇨병성 족부 궤양 부문의 점유율은 어떻게 되나요?
  • 디지털 상처 측정 기기 시장에서 비접촉 부문의 점유율은 어떻게 되나요?
  • 디지털 상처 측정 기기 시장에서 병원 및 진료소 부문의 점유율은 어떻게 되나요?
  • 디지털 상처 측정 기기 시장에서 북미의 점유율은 어떻게 되나요?

목차

제1장 디지털 창상 측정 기기 시장 : 서론

제2장 디지털 창상 측정 기기 시장 : 주요 요약

제3장 디지털 창상 측정 기기 시장 : 주요 요인 분석

제4장 AI, 지정학, 무역 및 경제 동향

제5장 규제 분석

제6장 Porter의 Five Forces 분석

제7장 디지털 창상 측정 기기 시장 : 평가

제8장 디지털 창상 측정 기기 시장 : 경쟁 구도

제9장 디지털 창상 측정 기기 시장 : 스타트업의 자금조달 및 투자 동향

제10장 디지털 창상 측정 기기 시장 : 기업 개요 및 제품 개요

제11장 KOL(Key Opinion Leader)의 견해

제12장 프로젝트 접근

제13장 DelveInsight에 대해

제14장 면책사항 및 문의

LSH 26.08.12

Digital Wound Measurement Devices Market Summary

Overview:

  • The Digital Wound Measurement Devices market is estimated at USD 260.5 million in 2025 and is projected to reach USD 552.7 million by 2034. Growth is anchored in the rising global burden of chronic and complex wounds, the shift from manual to imaging-led digital assessment, and expanding adoption of AI-enabled wound analytics across hospitals and specialty wound-care settings.
  • The global Digital Wound Measurement Devices market is growing at a CAGR of 8.5% during the forecast period from 2026 to 2034.
  • By product type, the software segment dominated the Digital Wound Measurement Devices market with a 58% share in 2025.
  • By measurement technology, the 2D imaging segment dominated the Digital Wound Measurement Devices market with a 50% share in 2025.
  • By wound type, the diabetic foot ulcers segment dominated the Digital Wound Measurement Devices market with a 38% share in 2025.
  • By modality, the non-contact segment dominated the Digital Wound Measurement Devices market with a 60% share in 2025.
  • By end-user, the hospitals & clinics segment dominated the Digital Wound Measurement Devices market with a 56% share in 2025.
  • North America dominated the global Digital Wound Measurement Devices market revenue with a 42% share in 2025, representing the highest regional market share globally.

A digital wound measurement device is a hardware- or software-enabled system that captures, quantifies, and documents wound dimensions, such as length, width, depth, area, and volume, with greater accuracy and consistency than manual methods such as rulers, acetate tracing, or visual estimation. Because chronic wounds, including diabetic foot ulcers, pressure injuries, and venous leg ulcers, require repeated evaluation over weeks or months, clinicians increasingly rely on digital measurement platforms that combine imaging sensors, structured light, laser scanning, or computer-vision algorithms to build a standardized, traceable visual history of healing progress. These solutions span dedicated hardware devices and standalone software applications, use technologies including 2D imaging, 3D imaging, AI and computer vision, and laser-based imaging, and are deployed across contact-based and non-contact modalities to assess diabetic foot ulcers, pressure ulcers and injuries, burns, and other wound types. The market is organized by product type across devices and software; by measurement technology, including 2D imaging, 3D imaging, AI and computer vision, laser-based imaging, and others; by wound type, led by diabetic foot ulcers, pressure ulcers/injuries, and burns; by modality across contact-based and non-contact systems; and by end-user, led by hospitals and clinics. Driven by the rising global prevalence of chronic wounds, the shift toward standardized, infection-control-friendly non-contact assessment, and the integration of AI-enabled analytics and EHR connectivity, digital wound measurement devices have become an increasingly essential component of modern, data-driven wound-care programs.

Digital Wound Measurement Devices Market Key Growth Drivers

  • The rising global burden of chronic and complex wounds, including diabetic foot ulcers, pressure injuries, and venous leg ulcers, is expanding demand for tools that support repeated, standardized assessment over long treatment cycles.
  • A structural shift away from manual, contact-based measurement toward non-contact, imaging-led assessment is accelerating adoption, as non-contact systems support infection control, reduce patient discomfort, and produce reviewable visual records.
  • Growing integration of artificial intelligence and computer vision into wound imaging platforms is improving measurement speed, consistency, and clinical decision support, exemplified by Swift Medical's AI-based Skin & Wound 2 platform launched in October 2024.
  • Rising investor and strategic interest in digital wound-care platforms is accelerating capacity build-out, including MolecuLight's USD 27.5 million investment from Hayfin Capital Management in January 2025.
  • Healthcare systems are pushing for better documentation quality, standardized wound assessment across clinicians, and stronger reimbursement support, favoring digital tools over rulers, paper notes, and subjective estimation.
  • Expanding digital transformation of wound care, including telehealth, remote patient monitoring, and EHR/EMR interoperability, is broadening the addressable market beyond hospitals into specialty clinics and home-based care.
  • The convergence of chronic-disease prevalence, non-contact and AI-enabled imaging adoption, and connected-care investment is expected to sustain steady growth in the market through 2034.

Key Companies in Digital Wound Measurement Devices Market

The competitive landscape is led by the following active device manufacturers:

  • MolecuLight Inc.
  • WoundMatrix, Inc.
  • Kent Imaging Inc.
  • ARANZ Medical Limited
  • WoundVision LLC
  • Stryker
  • eKare Inc.
  • Net Health
  • Perceptive Solutions, Inc.
  • BioVisual Technologies LLC
  • Smith & Nephew

Factors Contributing to the Growth of the Digital Wound Measurement Devices Market

Market Drivers

Rising Global Burden of Chronic and Complex Wounds

The most powerful driver of the Digital Wound Measurement Devices market is the steady increase in patients living with wounds that require repeated follow-up rather than one-time evaluation. Chronic wounds are closely tied to diabetes, immobility, vascular insufficiency, and advanced age, and they are becoming more visible as populations age and long-term disease management becomes more demanding. In the United States alone, over 6.5 million individuals live with chronic wounds, generating annual healthcare costs of approximately USD 25 billion, while similar burdens are reported across Germany, Australia, and other developed markets. In these cases, wound assessment is not a single measurement but an ongoing process of tracking progress, identifying delayed healing, and supporting timely changes in treatment. Digital measurement devices meet this need by creating a visual history of the wound and reducing variation between caregivers, particularly in settings where multiple clinicians see the same patient across several visits. As wound-care pathways become more structured, providers increasingly value tools that improve consistency and reduce guesswork, anchoring market growth through 2034.

Shift Toward Non-Contact, Imaging-Led Assessment

A structural shift away from manual and contact-based measurement toward non-contact, imaging-led assessment is reshaping the market. Non-contact systems allow clinicians to assess wounds without physically touching the site while capturing images that support measurement and documentation, which matters in modern wound care where infection control, patient comfort, and repeatable follow-up carry real weight. Providers increasingly value systems that support standardization across clinicians, especially in large hospitals and multi-site wound programs, helping imaging-based platforms that combine measurement with photo capture, software analysis, and structured documentation gain ground over rulers and acetate tracing.

Market Restraints

Despite steady momentum, the Digital Wound Measurement Devices market faces material constraints. Budget pressure and uneven clinical adoption remain a practical restraint, as many providers, particularly smaller facilities, outpatient centers, and institutions in cost-constrained markets, remain price-sensitive and may view digital measurement tools as appropriate but not essential when manual tools remain familiar and inexpensive. Workflow disruption is a further barrier: even when a device improves documentation quality, clinicians may hesitate to adopt it if it adds steps, requires training, or does not integrate smoothly with existing records systems. The market includes a fragmented mix of imaging, measurement, and documentation solutions, complicating purchasing decisions and requiring vendors to prove value not only in clinical terms but also in time savings and operational efficiency. Proving consistent clinical value across highly varied care settings, from hospitals and ambulatory surgical centers to specialty clinics and home-based care, remains a core challenge, since a device that performs well in a specialized wound center may not be readily adopted in a general hospital ward or resource-limited outpatient setting. Reimbursement variability across geographies, limited digital infrastructure in emerging markets, and the need to translate technical capability into measurable outcomes further temper the pace of adoption, even as the underlying drivers of chronic-wound prevalence and digital transformation remain firmly intact.

Digital Wound Measurement Devices Market Segment Analysis

The Digital Wound Measurement Devices by Market by Product Type (Devices and Software), Measurement Technology (2D Imaging, 3D Imaging, AI & Computer Vision, Laser-Based Imaging, and Others), Wound Type (Diabetic Foot Ulcers, Pressure Ulcers/Injuries, Burns, and Others), Modality (Contact-Based and Non-Contact), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product Type

Dominant Subsegment: Software.

Dominant: Software ~ 58%

The software segment accounted for 58% of the Digital Wound Measurement Devices market in 2025. Software is the leading product type because wound-care providers increasingly value the analytics, documentation, and EHR-integration layer as much as the underlying imaging hardware. Software platforms such as ARANZ Medical's Silhouette, eKare's inSight, and Net Health's Tissue Analytics deliver automated measurement, wound-progression tracking, and structured clinical records on top of standard smartphones or tablets, lowering the incremental hardware cost of adoption while enabling recurring, subscription-based revenue for vendors. The proliferation of smartphone-based imaging and cloud-hosted analytics has expanded software's reach into specialty clinics and home-based settings where dedicated hardware purchases are harder to justify.

While dedicated devices, including near-infrared and fluorescence-imaging hardware such as Kent Imaging's SnapshotNIR and MolecuLight's point-of-care imaging systems, continue to grow steadily on the strength of differentiated clinical capability, the breadth, scalability, and recurring-revenue economics of software platforms secure the segment's leadership across the forecast period.

By Measurement Technology

Dominant Subsegment: 2D Imaging.

Dominant: 2D Imaging ~ 50%

The 2D imaging segment accounted for 50% of the Digital Wound Measurement Devices market in 2025. 2D imaging is the leading measurement technology because it balances utility, cost, and ease of use. Two-dimensional imaging platforms give clinicians a fast, low-cost way to capture wound images, estimate dimensions, and build a visual timeline without the capital investment or learning curve associated with more advanced 3D or laser-based systems, making them the practical default across hospitals, specialty clinics, and lower-resource care settings.

AI and computer vision are the fastest-growing measurement technology, as platforms increasingly combine machine learning with structured light and photogrammetry to automate wound-border delineation and tissue classification, while 3D imaging is also expanding quickly on the strength of its ability to capture depth and volume, both critical for tracking healing in cavity wounds and deep pressure injuries. Laser-based imaging remains a smaller, specialized category valued for measurement precision in dedicated wound-care centers.

Digital Wound Measurement Devices Market Region Analysis

Dominant Region: North America

North America accounted for 42% of the global Digital Wound Measurement Devices market revenue in 2025, representing the highest regional market share globally. The region's leadership reflects advanced healthcare infrastructure, high adoption of medical imaging and digital documentation tools, and a strong presence of wound-care specialists across hospitals and outpatient settings. North America hosts the largest concentration of digital wound-care platform vendors, including ARANZ Medical, MolecuLight, eKare, Kent Imaging, and Net Health, and benefits from established reimbursement pathways and regulatory clarity through the FDA. The rising burden of chronic wounds, including diabetic foot ulcers and pressure injuries, combined with strong institutional purchasing power and EHR interoperability standards, drives substantial outsourced-imaging and software adoption. Continued investment, including MolecuLight's USD 27.5 million capital raise and Net Health's acquisition activity, is reinforcing the region's leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Digital Wound Measurement Devices market. The region's elevated CAGR is driven by expanding healthcare infrastructure, rising diabetes and chronic-wound prevalence, and growing awareness of digital wound-assessment tools across China, Japan, India, South Korea, and Australia. China is expanding hospital digitization and imaging infrastructure, Japan is integrating advanced wound-care technologies into its aging-population health strategy, and India is emerging as a growth market on the back of a large and rising diabetic population and expanding private hospital networks. Government healthcare investment, growing wound-care awareness, and the entry of global vendors into regional distribution partnerships are accelerating adoption, positioning Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 42% of the global Digital Wound Measurement Devices market revenue in 2025. The United States dominates on the strength of its advanced wound-care infrastructure, digital-health adoption, FDA regulatory clarity, and concentration of leading device and software vendors, while continued capital investment and EHR-integration initiatives reinforce the region's leadership.

Europe

Europe is a large and advanced regional market, supported by an aging population, rising chronic-wound incidence affecting up to 14.9 million people, and growing institutional focus on standardized wound-care quality. Vendors such as ARANZ Medical are expanding regional partnerships, while providers such as Smith & Nephew are showcasing integrated wound-care innovation at forums including the European Wound Management Association conference, reinforcing the region's role as a mature, quality-driven market across Germany, the United Kingdom, France, Italy, and Spain.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by expanding healthcare infrastructure, rising diabetes and chronic-wound prevalence, and growing digital-health investment across China, Japan, India, South Korea, and Australia. Expanding hospital networks and rising awareness of standardized, non-contact wound assessment are accelerating regional adoption and clinical-partnership activity.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital infrastructure, rising diabetes prevalence, and gradual adoption of digital documentation practices are broadening access, while international distribution partnerships support the build-out of regional wound-care imaging capacity.

Digital Wound Measurement Devices Market Competitive Landscape

The Digital Wound Measurement Devices market is classified as Moderately Fragmented. A group of established medical-technology players with broad wound-care portfolios and global distribution, including Smith & Nephew and Stryker, compete alongside specialized imaging and software innovators such as MolecuLight, ARANZ Medical, eKare, Kent Imaging, WoundVision, and Net Health, which differentiate through measurement accuracy, AI-enabled analytics, and EHR integration. Emerging players including WoundMatrix, Perceptive Solutions, and BioVisual Technologies compete through focused product innovation and channel partnerships, increasing competition in the fastest-growing non-contact and AI-enabled segments.

The competitive landscape can be evaluated across the following dimensions:

  • Market concentration: Moderately fragmented, with diversified medical-technology leaders and a fast-growing field of specialized imaging and software innovators.
  • Leading players: ARANZ Medical, MolecuLight, Net Health, Smith & Nephew, and eKare anchor the top tier through installed base, distribution reach, and clinical validation.
  • Geographic reach: Leaders operate multi-country distribution networks; Kent Imaging's December 2025 exclusive U.S. distribution agreement with New Horizon Medical Solutions spans all 48 contiguous states.
  • Product portfolio strength: Top players offer end-to-end imaging hardware, AI-enabled software, telehealth integration, and EHR/EMR connectivity through HL7 and FHIR protocols.
  • Technology differentiation: Near-infrared and fluorescence imaging (Kent Imaging, MolecuLight), structured-light 3D imaging (eKare), and cloud-based documentation platforms (ARANZ Medical, Net Health) are key competitive moats.
  • Strategic partnerships: Tie-ups with distributors and care-delivery networks, such as ARANZ Medical's partnership with Wound Care Plus and Kent Imaging's agreement with New Horizon Medical Solutions, extend market reach.
  • M&A and investment activity: Active investment, including MolecuLight's USD 27.5 million Hayfin Capital raise and Net Health's acquisitions of Limber Health and Keet Health, is reshaping platform capabilities.
  • Clinical validation: Peer-reviewed inter-rater and intra-rater reliability studies, such as those supporting eKare's inSight platform, are an increasingly important competitive differentiator.
  • Innovation focus: AI-enabled measurement, non-contact and multimodal imaging, telehealth-enabled remote monitoring, and deeper EHR interoperability define the next wave of competitive advantage.

Digital Wound Measurement Devices Market Recent Developmental Activities

In December 2025, Kent Imaging Inc. signed an exclusive U.S. distribution agreement with New Horizon Medical Solutions covering all 48 contiguous states for its Snapshot family of near-infrared and bacterial-autofluorescence imaging devices, including SnapshotNIR and SnapshotGLO. Strategic significance: Expands U.S. commercial reach and strengthens Kent Imaging's position in point-of-care perfusion and bioburden imaging.

In January 2026, Net Health opened registration for its NEXT client conference and continued expanding its AI-native wound-care and outcomes-analytics platform across its restorative-care software portfolio. Strategic significance: Reinforces Net Health's software leadership and deepens client engagement across its wound-care EHR ecosystem.

Digital Wound Measurement Devices Market Segmentation

Digital Wound Measurement Devices Market by Product Type

  • Devices
  • Software

Digital Wound Measurement Devices Market by Measurement Technology

  • 2D Imaging
  • 3D Imaging
  • AI & Computer Vision
  • Laser-Based Imaging
  • Others

Digital Wound Measurement Devices Market by Wound Type

  • Diabetic Foot Ulcers
  • Pressure Ulcers/Injuries
  • Burns
  • Others

Digital Wound Measurement Devices Market by Modality

  • Contact-Based
  • Non-Contact

Digital Wound Measurement Devices Market by End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Digital Wound Measurement Devices Market by Geography

  • North America Digital Wound Measurement Devices Market
  • United States Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Canada Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Mexico Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Europe Digital Wound Measurement Devices Market
  • Germany Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • United Kingdom Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • France Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Italy Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Spain Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Rest of Europe Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Asia-Pacific Digital Wound Measurement Devices Market
  • China Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Japan Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • India Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Australia Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • South Korea Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Rest of the World (RoW) Digital Wound Measurement Devices Market
  • Middle East Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • Africa Digital Wound Measurement Devices Market Size in USD million (2023-2034)
  • South America Digital Wound Measurement Devices Market Size in USD million (2023-2034)

Key Takeaways from the Digital Wound Measurement Devices Market Report Study

  • Market size analysis for the current digital wound measurement devices market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global digital wound measurement devices market.
  • Various opportunities available for competitors in the digital wound measurement devices market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current digital wound measurement devices market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for digital wound measurement devices market growth in the future?

Target audience who can benefit from this Digital Wound Measurement Devices market report study

  • Digital wound measurement devices product providers
  • Research organizations and consulting companies
  • Digital wound measurement devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in digital wound measurement devices
  • Various end-users who want to know more about the digital wound measurement devices market and the latest technological developments in the digital wound measurement devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the digital wound measurement devices market?

The digital wound measurement devices market is projected to expand at a CAGR of 8.5% during the forecast period from 2026-2034.

Q2. What is the market size of the digital wound measurement devices market?

The digital wound measurement devices market is estimated at USD 260.5 million in 2025 and is projected to reach USD 552.7 million by 2034.

Q3. Which region dominates the digital wound measurement devices market?

North America dominated the digital wound measurement devices market with a 42% share of global revenue in 2025, supported by advanced healthcare infrastructure, high adoption of digital documentation tools, strong reimbursement pathways, and the largest concentration of leading device and software vendors. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the digital wound measurement devices market?

The principal drivers are the rising global burden of chronic and complex wounds, including diabetic foot ulcers and pressure injuries; the structural shift toward non-contact, imaging-led assessment; growing integration of AI and computer vision into wound-imaging platforms; rising investor and strategic interest, exemplified by MolecuLight's USD 27.5 million capital raise; and the push for standardized documentation and reimbursement support.

Q5. Who are the major players in the digital wound measurement devices market?

The major players include MolecuLight Inc., WoundMatrix, Inc., Kent Imaging Inc., ARANZ Medical Limited, WoundVision LLC, Stryker, eKare Inc., Net Health, Perceptive Solutions, Inc., and BioVisual Technologies LLC, among other active providers profiled in the Competitive Landscape section, along with Smith & Nephew and Swift Medical Inc. ARANZ Medical, MolecuLight, Net Health, and Smith & Nephew lead through installed base, distribution reach, and clinical validation.

Table of Contents

1. Digital Wound Measurement Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumptions

2. Digital Wound Measurement Devices Market Executive Summary

  • 2.1 Market at a Glance

3. Digital Wound Measurement Devices Market Key Factors Analysis

  • 3.1 Digital Wound Measurement Devices Market Drivers
    • 3.1.1 Rising Burden of Chronic and Complex Wounds
    • 3.1.2 Shift towards Non-Contact, Imaging-Led Assessment
    • 3.1.3 Growing Integration of AI and Computer Vision
    • 3.1.4 Rising Investor and Strategic Interest
  • 3.2 Digital Wound Measurement Devices Market Restraints and Challenges
    • 3.2.1 Budget Pressure and Uneven Clinical Adoption
    • 3.2.2 Workflow Integration and Fragmented Purchasing
    • 3.2.3 Proving Clinical Value across Diverse Care Settings
  • 3.3 Digital Wound Measurement Devices Market Opportunities
    • 3.3.1 AI-Enabled and Non-Contact Imaging Expansion
    • 3.3.2 Telehealth, Remote Monitoring, and Connected Care

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1 United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Digital Wound Measurement Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Buyers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Digital Wound Measurement Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Devices
    • 7.1.2 Software
  • 7.2 By Measurement Technology
    • 7.2.1 2D Imaging
    • 7.2.2 3D Imaging
    • 7.2.3 AI & Computer Vision
    • 7.2.4 Laser-Based Imaging
    • 7.2.5 Others
  • 7.3 By Wound Type
    • 7.3.1 Diabetic Foot Ulcers
    • 7.3.2 Pressure Ulcers/Injuries
    • 7.3.3 Burns
    • 7.3.4 Others
  • 7.4 By Modality
    • 7.4.1 Contact-Based
    • 7.4.2 Non-Contact
  • 7.5 By End-User
    • 7.5.1 Hospitals & Clinics
    • 7.5.2 Ambulatory Surgical Centers
    • 7.5.3 Others
  • 7.6 By Geography
    • 7.6.1 North America
      • 7.6.1.1 United States Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.1.2 Canada Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.1.3 Mexico Digital Wound Measurement Devices Market Size in USD million (2023-2034)
    • 7.6.2 Europe
      • 7.6.2.1 Germany Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.2.2 United Kingdom Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.2.3 France Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.2.4 Italy Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.2.5 Spain Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.2.6 Rest of Europe Digital Wound Measurement Devices Market Size in USD million (2023-2034)
    • 7.6.3 Asia-Pacific
      • 7.6.3.1 China Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.3.2 Japan Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.3.3 India Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.3.4 Australia Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.3.5 South Korea Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.3.6 Rest of Asia-Pacific Digital Wound Measurement Devices Market Size in USD million (2023-2034)
    • 7.6.4 Rest of World
      • 7.6.4.1 Middle East Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.4.2 Africa Digital Wound Measurement Devices Market Size in USD million (2023-2034)
      • 7.6.4.3 South America Digital Wound Measurement Devices Market Size in USD million (2023-2034)

8. Digital Wound Measurement Devices Market Competitive Landscape

  • 8.1 Market Concentration and Structure
  • 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Digital Wound Measurement Devices Market Startup Funding and Investment Trends

10. Digital Wound Measurement Devices Market Company and Product Profiles

  • 10.1 MolecuLight Inc.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Service Portfolio
    • 10.1.5 Strategic Initiatives / Entropy
  • 10.2 WoundMatrix, Inc.
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Portfolio
    • 10.2.5 Strategic Initiatives / Entropy
  • 10.3 Kent Imaging Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 Strategic Initiatives / Entropy
  • 10.4 ARANZ Medical Limited
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 Strategic Initiatives / Entropy
  • 10.5 WoundVision LLC
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 Strategic Initiatives / Entropy
  • 10.6 Stryker
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 Strategic Initiatives / Entropy
  • 10.7 eKare Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 Strategic Initiatives / Entropy
  • 10.8 Net Health
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 Strategic Initiatives / Entropy
  • 10.9 Perceptive Solutions, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 Strategic Initiatives / Entropy
  • 10. 10 BioVisual Technologies LLC
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Portfolio
    • 10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기